PRAME expression is not associated with down-regulation of retinoic acid signaling in primary acute myeloid leukemia

Cancer Genetics and Cytogenetics

Volumn 177, Issue 1, 2007, Pages 51-54

  Steinbach, Daniel ^a,b   Pfaffendorf, Nadine ^b   Wittig, Susan ^b   Gruhn, Bernd ^b  

^a UNIVERSITY HOSPITAL ULM   (Germany)

^b JENA UNIVERSITY HOSPITAL   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

CALCIUM BINDING PROTEIN; COMPLEMENTARY DNA; CYCLIN DEPENDENT KINASE INHIBITOR 1A; HEAT SHOCK PROTEIN; PREFERENTIALLY EXPRESSED ANTIGEN OF MELANOMA; RETINOIC ACID RECEPTOR BETA; TUMOR ANTIGEN; UNCLASSIFIED DRUG;

ACUTE GRANULOCYTIC LEUKEMIA; ADOLESCENT; ADULT; ARTICLE; CHILD; CHROMOSOME TRANSLOCATION; DOWN REGULATION; FEMALE; GENE EXPRESSION REGULATION; HUMAN; INFANT; LEUKEMIA CELL; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; REAL TIME POLYMERASE CHAIN REACTION;

ACUTE DISEASE; ADOLESCENT; ADULT; ANTIGENS, NEOPLASM; CHILD; CHILD, PRESCHOOL; CYCLIN-DEPENDENT KINASE INHIBITOR P21; DNA-BINDING PROTEINS; DOWN-REGULATION; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; HEAT-SHOCK PROTEINS; HUMANS; INFANT; INFANT, NEWBORN; LEUKEMIA, MYELOID; MALE; NEOPLASM PROTEINS; RECEPTORS, RETINOIC ACID; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; RNA, NEOPLASM; S100 PROTEINS; SIGNAL TRANSDUCTION; TRANSCRIPTION FACTORS; TRETINOIN; TUMOR MARKERS, BIOLOGICAL;

EID: 34547682277     PISSN: 01654608     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cancergencyto.2007.05.011     Document Type: Article

References (14)

1. Epping M.T., and Bernards R. A causal role for the human tumor antigen preferentially expressed antigen of melanoma in cancer. Cancer Res 66 (2006) 10639-10642
2. Steinbach D., Hermann J., Viehmann S., Zintl F., and Gruhn B. Clinical implications of PRAME gene expression in childhood acute myeloid leukemia. Cancer Genet Cytogenet 133 (2002) 118-123
3. Haqq C., Nosrati M., Sudilovsky D., Crothers J., Khodabakhsh D., Pulliam B.L., Federman S., Miller III J.R., Allen R.E., Singer M.I., Leong S.P., Ljung B.M., Sagebiel R.W., and Kashani-Sabet M. The gene expression signatures of melanoma progression. Proc Natl Acad Sci USA 102 (2005) 6092-6097
4. Oberthuer A., Hero B., Spitz R., Berthold F., and Fischer M. The tumor-associated antigen PRAME is universally expressed in high-stage neuroblastoma and associated with poor outcome. Clin Cancer Res 10 (2004) 4307-4313
5. Radich J.P., Dai H., Mao M., Oehler V., Schelter J., Druker B., Sawyers C., Shah N., Stock W., Willman C.L., Friend S., and Linsley P.S. Gene expression changes associated with progression and response in chronic myeloid leukemia. Proc Natl Acad Sci USA 103 (2006) 2794-2799
6. Epping M.T., Wang L., Edel M.J., Carlee L., Hernandez M., and Bernards R. The human tumor antigen PRAME is a dominant repressor of retinoic acid receptor signaling. Cell 122 (2005) 835-847
7. de The H., Vivanco-Ruiz M.M., Tiollais P., Stunnenberg H., and Dejean A. Identification of a retinoic acid responsive element in the retinoic acid receptor beta gene. Nature 343 (1990) 177-180
8. Liu M., Iavarone A., and Freedman L.P. Transcriptional activation of the human p21(WAF1/CIP1) gene by retinoic acid receptor. Correlation with retinoid induction of U937 cell differentiation. J Biol Chem 271 (1996) 31723-31728
9. Tajeddine N., Gala J.L., Louis M., Van Schoor M., Tombal B., and Gailly P. Tumor-associated antigen preferentially expressed antigen of melanoma (PRAME) induces caspase-independent cell death in vitro and reduces tumorigenicity in vivo. Cancer Res 65 (2005) 7348-7355
10. Creutzig U., Zimmermann M., Reinhardt D., Dworzak M., Stary J., and Lehrnbecher T. Early deaths and treatment-related mortality in children undergoing therapy for acute myeloid leukemia: analysis of the multicenter clinical trials AML-BFM 93 and AML-BFM 98. J Clin Oncol 22 (2004) 4384-4393
11. Weisser M., Haferlach T., Schoch C., Hiddemann W., and Schnittger S. The use of housekeeping genes for real-time PCR-based quantification of fusion gene transcripts in acute myeloid leukemia. Leukemia 18 (2004) 1551-1553
12. Steinbach D., Schramm A., Eggert A., Onda M., Dawczynski K., Rump A., Pastan I., Wittig S., Pfaffendorf N., Voigt A., Zintl F., and Gruhn B. Identification of a set of seven genes for the monitoring of minimal residual disease in pediatric acute myeloid leukemia. Clin Cancer Res 12 (2006) 2434-2441
13. Goellner S., Steinbach D., Schenk T., Gruhn B., Zintl F., Ramsay E., and Saluz H.P. Childhood acute myelogenous leukaemia: association between PRAME, apoptosis- and MDR-related gene expression. Eur J Cancer 42 (2006) 2807-2814
14. Steinbach D., Viehmann S., Zintl F., and Gruhn B. PRAME gene expression in childhood acute lymphoblastic leukemia. Cancer Genet Cytogenet 138 (2002) 89-91